All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
FTC Notices of Penalty Offenses: What Should You Do?
By Mark Land, M.S., RAC, AAHP President Most of you have probably seen media mentions about almost 700 "Notices of Penalty Offenses" sent by the...
In Conversation with Homeopathic Industry Veteran J.P. Borneman
Dr. John "Jay" Borneman was born into the field of homeopathy. His great-grandfather, grandfather, and father paved the way before him through their own extensive...
What’s In a Name?
By Al Lorman, AAHP Counsel FDA's issuance of its new guidance on homeopath drugs in December, 2022 has caused concern in some quarters because of...
A Retrospective Policy Analysis of FDA’s CPG 400.400
The origins of FDA's CPG 400.400 go back to a series of meetings between industry and Agency enforcement personnel in the 1980s. The resulting CPG...
The Regulation of Homeopathic Drug Products
Statutory Recognition of Homeopathic Drugs Since the passage of the Federal Food, Drug, and Cosmetic Act (FDCA) in 1938, homeopathic drugs are the only form...
AAHP Annual Meeting, Report Recap and Election Results.
The AAHP held the annual membership meeting in Mid-March. The largest number of people attended this meeting than any other in the association's history. In...
Regulation in Homeopathy
This month we will discuss policy outcomes from FDA's policy and enforcement guidance documents past and present for homeopathic drug products. In our first article,...
